BofA Wows Critics and 3 Heavily Traded Stocks Mid-Week

Annaly Capital Management, Inc. (NYSE:NLY): Citigroup lowered their price target for real estate investment trust Annaly Capital Management, Inc. They have reaffirmed a Neutral rating for the company and have lowered their price target from $17 to $15. This price target suggests a slight decrease from the stock’s current price of $15.05.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

Bank of America Corp (NYSE:BAC): Bank of America Corp.  felt some heat over their aborted $5 monthly debit card fee and their recent untenable requirements, since reversed, for customers in Sandy’s path to receive fee waivers. However, in a recent report issued by the research and consulting firm Celent, the bank received top scores for new customer assistance at branch locations as well as for being well-versed in the subtleties of mobile banking. In fact, Bank of America did so well that they earned the firm’s XCelent Service Award.

Citigroup Inc. (NYSE:C): According to Reuters, Citigroup Inc. and UBS (NYSE:UBS) have teamed up to offer settlement, clearing, asset servicing and custody capabilities to broker-dealers in the Asian-Pacific region.

Pfizer (NYSE:PFE): According to Wall Street analysts, as the world awaited results from the United States presidential election, Pfizer scored their own goal. They received the approval for Xeljanz, a pill that treats Rheumatoid Arthritis. Pfizer believes that this drug has the potential to generate a few billion dollars a year in revenue.

Don’t Miss: Multivitamin Study Could Be Bad News for These Stocks.